CLINICAL TRIAL

Exercise Prescription for COVID-19

Waitlist Available · 18+ · All Sexes · Frisco, TX

Exercise in Adults With Post-Acute Sequelae of SARS-CoV-2 (COVID-19) Infection Study

See full description

About the trial for COVID-19

Treatment Groups

This trial involves 2 different treatments. Exercise Prescription is the primary treatment being studied. Participants will all receive the same treatment. Some patients will receive a placebo treatment. The treatments being tested are not being studied for commercial purposes.

Main TreatmentA portion of participants receive this new treatment to see if it outperforms the control.
Exercise Prescription
OTHER
Control TreatmentAnother portion of participants receive the standard treatment to act as a baseline.
Exercise Prescription
OTHER

Eligibility

This trial is for patients born any sex aged 18 and older. There are 3 eligibility criteria to participate in this trial as listed below.

Inclusion & Exclusion Checklist
Mark “yes” if the following statements are true for you:
You are between the ages of 18 and 65. show original
Self-reported history of COVID-19 diagnosis. show original
You have ongoing symptoms of PANDAS. show original
View All
Odds of Eligibility
Unknown<50%
Be sure to apply to 2-3 other trials, as you have a low likelihood of qualifying for this one.Apply To This Trial
Similar Trials

Approximate Timelines

Please note that timelines for treatment and screening will vary by patient
Screening: ~3 weeks
Treatment: varies
Reporting: Lasting 26 weeks.
Screening: ~3 weeks
Treatment: Varies
Reporting: Lasting 26 weeks.
This trial has approximate timelines as follows: 3 weeks for initial screening, variable treatment timelines, and reporting: Lasting 26 weeks..
View detailed reporting requirements
Trial Expert
Connect with the researchersHop on a 15 minute call & ask questions about:
- What options you have available- The pros & cons of this trial
- Whether you're likely to qualify- What the enrollment process looks like

Measurement Requirements

This trial is evaluating whether Exercise Prescription will improve 3 primary outcomes and 43 secondary outcomes in patients with COVID-19. Measurement will happen over the course of At third assessment, during week 20..

Pulse oximetry
AT THIRD ASSESSMENT, DURING WEEK 20.
Measured by a pulse oximeter during each stage of the exercise protocol of the cardiopulmonary exercise test on a cycle ergometer.
AT THIRD ASSESSMENT, DURING WEEK 20.
VO2/Heart Rate, mL/beat
AT THIRD ASSESSMENT, DURING WEEK 20.
Using metabolic cart, VO2/heart rate will be recorded.
AT THIRD ASSESSMENT, DURING WEEK 20.
Duration, mm:ss
AT THIRD ASSESSMENT, DURING WEEK 20.
Total time of test (CPET).
AT THIRD ASSESSMENT, DURING WEEK 20.
Metabolic Equivalents
AT THIRD ASSESSMENT, DURING WEEK 20.
Using metabolic cart, metabolic equivalents will be recorded.
AT THIRD ASSESSMENT, DURING WEEK 20.
Tidal Volume, L
AT THIRD ASSESSMENT, DURING WEEK 20.
Using metabolic cart, tidal volume will be recorded.
AT THIRD ASSESSMENT, DURING WEEK 20.
Inhibition on CogPT app
AT THIRD ASSESSMENT, DURING WEEK 20.
Using the Sports Academy CogPT iPad application, inhibition will be recorded.
AT THIRD ASSESSMENT, DURING WEEK 20.
See More

Who is running the study

Principal Investigator
S.
Simonver, Research Center Director - The STAR at Frisco
Baylor Research Institute

Patient Q & A Section

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What causes covid-19?

There are three key drivers of spread of the virus: the host genetic factors (for example, genetic variants in the MHC class II and other genes; the immune response; and the host-pathogen relationship), as well as the non-host-environment factors (for example, changes in behavior and immunity). The non-host-environment factors (for example, the change in the interaction of the virus with the human metaproteome of the host cells) could influence viral fitness, allowing a temporary or permanent amplification of the virus in the host, and, ultimately, the spread of the virus.

Anonymous Patient Answer

How many people get covid-19 a year in the United States?

There are an estimated 100,000 new cases of coronavirus illness in the United States per year. A significant portion of patients presenting with fever to the emergency department are testing positive for coronavirus.

Anonymous Patient Answer

Can covid-19 be cured?

There is no evidence of a short-term cure of the illness, even as the current clinical course worsens. Future research is required to explore the long-term impact of this virus, beyond its own symptomatology. If the current course of the disease continues, it could become untreatable from an integrated perspective with any potential cure, and could become a public health crisis because the health-care system will be overwhelmed.

Anonymous Patient Answer

What are the signs of covid-19?

Most patients with fever and myalgia had mild symptoms, only 1 of 12 was confirmed. The cases are similar to the common flu. It can cause short term myalgia, a high fever and loss of appetite, but no fatalities or disease progression observed yet. Therefore, the effect of the virus is thought to be low. There is no evidence that the virus can cause more harm than the common flu.\n

Anonymous Patient Answer

What are common treatments for covid-19?

Treatment for covid-19 is largely centered on symptoms and symptoms-based measures. For more severely ill persons or those with underlying comorbidities, there is a need for novel approaches, including interventions that prevent the progression to chronic phase and possibly a combination with medications.

Anonymous Patient Answer

What is covid-19?

We emphasize the need for public education about the epidemiology of the coronavirus disease (COVID-19) due to the rapid spread of misinformation on the internet and social media.

Anonymous Patient Answer

What is the primary cause of covid-19?

The majority of cases of SARS and MERS seemed to be related to travel (60.7% and 55.5%, respectively), which is the same as previously reported in the current epidemic of SARS-CoV-2 (80.5% for both) and the primary cause of SARS and MERS. A lower percentage of cases of SARS were thought to be related to contact tracing (9.1% and 3.5%, respectively) in Hong Kong. These data do not exclude the possible role of the virus as a second intermediary host in humans, or that it can be transmitted through direct or indirect contact.

Anonymous Patient Answer

What are the common side effects of exercise prescription?

Compared to usual care and pharmacological, exercise prescription alone leads to improvements in several outcome variables, but there are limited data on whether exercise prescription alone lead to a reduction in the exacerbation rate or disease burden.

Anonymous Patient Answer

What is the average age someone gets covid-19?

There is variation and correlation between the age at onset of symptoms in various geographic areas. This could be due to an outbreak in certain areas or may represent differences in the viral strains in the populations. The average age for onset of symptoms among patients in this outbreak in Zhejiang Province is 44.2 years. Further epidemiological evaluation and clinical work is urgently needed to improve disease control on the virus and avoid unnecessary diagnosis and treatment.

Anonymous Patient Answer

Has exercise prescription proven to be more effective than a placebo?

Exercise prescription of a moderate or high intensity with at least two types of exercise per week in patients with severe COPD reduces the decline in FEV1 during 12 months of treatment by 50–75% and it can delay the decline in 6 min. The decline in FEV1 was more pronounced in patients with low exercise tolerance and in patients who did not increase exercise intensity.

Anonymous Patient Answer

What is the latest research for covid-19?

Covid-19 continues to be an interesting disease that we should be researching and researching. We are working with others all over the world who have a similar disease called SARS-CoV-2 and we are working on understanding it. Covid-19 is still a major health crisis we are facing globally, and we are still working to understand the disease.

Anonymous Patient Answer

Who should consider clinical trials for covid-19?

The high prevalence of underlying medical conditions for elderly patients, including cardiovascular comorbidities, may make patients at higher risk for clinical trials. Conversely, the high prevalence of comorbidities may lower CVR scores and reduce the risk of patients developing infectious complications should they participate in clinical trials.

Anonymous Patient Answer
See if you qualify for this trial
Get access to this novel treatment for COVID-19 by sharing your contact details with the study coordinator.